CYP24A1 splice variants--implications for the antitumorigenic actions of 1,25-(OH)2D3 in colorectal cancer.

MLA

Horváth, H. C., et al. “CYP24A1 Splice Variants--Implications for the Antitumorigenic Actions of 1,25-(OH)2D3 in Colorectal Cancer.” The Journal of Steroid Biochemistry and Molecular Biology, vol. 121, no. 1–2, July 2010, pp. 76–79. EBSCOhost, https://doi.org/10.1016/j.jsbmb.2010.03.080.

APA

Horváth, H. C., Khabir, Z., Nittke, T., Gruber, S., Speer, G., Manhardt, T., Bonner, E., & Kallay, E. (2010). CYP24A1 splice variants--implications for the antitumorigenic actions of 1,25-(OH)2D3 in colorectal cancer. The Journal of Steroid Biochemistry and Molecular Biology, 121(1–2), 76–79. https://doi.org/10.1016/j.jsbmb.2010.03.080

Chicago

Horváth, H C, Z Khabir, T Nittke, S Gruber, G Speer, T Manhardt, E Bonner, and E Kallay. 2010. “CYP24A1 Splice Variants--Implications for the Antitumorigenic Actions of 1,25-(OH)2D3 in Colorectal Cancer.” The Journal of Steroid Biochemistry and Molecular Biology 121 (1–2): 76–79. doi:10.1016/j.jsbmb.2010.03.080.